Webster Bank N. A. Buys 177 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Webster Bank N. A. boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 10.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,911 shares of the healthcare conglomerate’s stock after purchasing an additional 177 shares during the quarter. Webster Bank N. A.’s holdings in UnitedHealth Group were worth $1,117,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently added to or reduced their stakes in UNH. Sound Income Strategies LLC raised its stake in UnitedHealth Group by 1.5% in the third quarter. Sound Income Strategies LLC now owns 1,940 shares of the healthcare conglomerate’s stock valued at $1,134,000 after buying an additional 29 shares during the last quarter. CVA Family Office LLC raised its stake in UnitedHealth Group by 4.5% in the third quarter. CVA Family Office LLC now owns 2,322 shares of the healthcare conglomerate’s stock valued at $1,358,000 after buying an additional 99 shares during the last quarter. Gilman Hill Asset Management LLC purchased a new stake in UnitedHealth Group in the third quarter valued at about $215,000. McGlone Suttner Wealth Management Inc. raised its stake in shares of UnitedHealth Group by 28.0% in the third quarter. McGlone Suttner Wealth Management Inc. now owns 1,594 shares of the healthcare conglomerate’s stock worth $932,000 after purchasing an additional 349 shares during the last quarter. Finally, Crestmont Private Wealth LLC purchased a new position in UnitedHealth Group during the third quarter valued at approximately $217,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.1 %

UNH traded up $0.35 on Friday, hitting $598.05. 1,909,733 shares of the company were exchanged, compared to its average volume of 2,855,968. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $607.94. The company has a market cap of $552.25 billion, a price-to-earnings ratio of 39.66, a price-to-earnings-growth ratio of 1.66 and a beta of 0.58. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. The firm has a 50-day moving average price of $583.64 and a two-hundred day moving average price of $531.08.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.66 by $0.14. The business had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $6.14 EPS. On average, equities analysts predict that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.40%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is 55.70%.

Analyst Ratings Changes

Several analysts have commented on the company. Robert W. Baird raised their price objective on UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a report on Wednesday, July 17th. UBS Group lifted their price objective on UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a research report on Thursday, July 18th. Argus lifted their price objective on UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. Jefferies Financial Group upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $481.00 to $647.00 in a research report on Wednesday, July 17th. Finally, Royal Bank of Canada lifted their price objective on UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 17th. Two analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus price target of $617.37.

Insider Transactions at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other news, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares in the company, valued at $4,507,748.55. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.